Canaccord Genuity analyst John Young CFA has maintained their neutral stance on STAA stock, giving a Hold rating yesterday.Stay Ahead of the ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

It was revealed in a recent SEC filing that BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical (NASDAQ:STAA) made a noteworthy insider purchase on December 19,. What Happened: In a recent Form 4 ...

STAAR Surgical (NASDAQ:STAA – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday .The company traded as low as $23.55 and last traded at $23.75, with a ...

ProDex (PDEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

STAAR Surgical (NASDAQ:STAA – Get Free Report) has earned an average rating of “Hold” from the nine research firms that are presently covering the company, MarketBeat Ratings reports.

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos Morgan Stanley upgrades key MedTech stocks ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical ...